X0306 4 2020-04-30 0 0001412408 Phreesia, Inc. PHR 0001776863 VanDuyn Amy Beth C/O PHREESIA, INC. 432 PARK AVENUE SOUTH, 12TH FLOOR NEW YORK NY 10016 0 1 0 0 SVP, Human Resources Common Stock 2020-04-30 4 A 0 1806 0.00 A 44892 D Common Stock 2020-04-30 4 F 0 625 23.67 D 44267 D Common Stock 2020-05-01 4 M 0 13474 2.03 A 57741 D Common Stock 2020-05-01 4 S 0 3900 24.6649 D 53841 D Common Stock 2020-05-01 4 S 0 9574 24.9627 D 44267 D Stock Option (Right to Buy) 2.03 2020-05-01 4 M 0 13474 0.00 D 2024-12-18 Common Stock 13474 9281 D On August 5, 2019, the Reporting Person was granted certain performance-based Restricted Stock Units ("RSUs") under the Phreesia, Inc. 2019 Stock Option and Incentive Plan, the vesting of which was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,806 RSUs. A portion of these shares represent RSUs. Each RSU respesents a contingent right to receive one share of the Issuer's common stock. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs and does not represent a sale by the Reporting Person. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.82 to $24.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.82 to $25.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This option is fully vested and exercisable as of the date hereof. /s/ Charles Kallenbach by Power of Attorney for Amy Beth VanDuyn 2020-05-04